Related by context. Frequent words. (Click for all words.) 64 ongoing Phase 1b 62 phase IIa clinical 62 dacetuzumab 61 HGS ETR2 61 Phase Ib clinical 61 phase IIb clinical 60 Pivotal Phase III 60 Initiates Phase II 59 Phase Ib II 59 Initiate Phase 59 bicifadine 59 forodesine 58 Cloretazine R VNP#M 58 ABSORB trial 58 elotuzumab 58 phase Ib 58 placebo controlled clinical 57 confirmatory Phase III 57 placebo controlled Phase 57 phase IIa 57 multicenter Phase 57 Phase 1b clinical 57 Phase 1b trial 57 Pivotal Phase 57 relapsed refractory multiple myeloma 57 R sorafenib tablets 56 Cethrin 56 TOLAMBA 56 nonrandomized 56 GRNVAC1 56 KRN# 56 squalamine 56 Phase 2a trial 56 IMC #B 56 Phase IIIb 56 TELCYTA 56 PEG SN# 56 PEG PAL 56 ThermoDox R 56 omecamtiv mecarbil 56 refractory chronic lymphocytic 56 multicenter prospective 55 Phase IIa clinical 55 drug eluting coronary stent 55 relapsing multiple sclerosis 55 phase IIb 55 INTERCEPT red 55 CIMZIA TM 55 Aurexis 55 Daclizumab 55 Phase IIB 55 Commences Phase 54 PLK1 SNALP 54 AVADO 54 Canvaxin 54 Phase 1b 54 Randomized controlled 54 Omigard 54 senicapoc 54 GLPG# 54 MKC# 54 celgosivir 54 PROPEL trial 54 nab paclitaxel 54 ocrelizumab 54 Fibrillex TM 54 Phase IIb clinical 54 unblinding 54 SAR# [004] 54 Phase 2a clinical 54 Secondary endpoints include 53 REOLYSIN ® 53 ONTAK 53 teriflunomide 53 Phase 2b trial 53 PEGPH# 53 Phase III pivotal 53 pharmacokinetics PK 53 Bicifadine 53 SPIRIT III 53 Phase 1a 53 GVAX R 53 Pivotal Trial 53 Sulonex 53 Amrubicin 53 Allovectin 7 R 53 Gabapentin GR 53 QLT# 53 metastatic hormone refractory 52 Azedra 52 Virulizin R 52 prospective multicenter 52 MAXY G# 52 OMS#HP 52 SPIRIT IV 52 axitinib 52 Prestara 52 Board DSMB 52 sunitinib malate 52 IIa trial 52 CALGB